These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 11796314)
1. Vasoactive agents induce cytotoxicity in cultured human penile smooth muscle cells. Rajasekaran M; Pagnon V; Monga M Urology; 2002 Jan; 59(1):155-8. PubMed ID: 11796314 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis. Schultheiss D; Pilatz A; Gabouev AI; Schlote N; Wefer J; Mertsching H; Sohn M; Jonas U; Stief CG Urology; 2004 Sep; 64(3):598-602. PubMed ID: 15351616 [TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of sildenafil on relaxation of rabbit and rat cavernosal smooth muscles when combined with various vasoactive agents. Seo KK; Kim SC; Jun IO; Oh MM; Lee MY BJU Int; 2001 Oct; 88(6):596-601. PubMed ID: 11678758 [TBL] [Abstract][Full Text] [Related]
4. In vitro viability of human cavernosal endothelial and fibroblastic cells after exposure to papaverine/phentolamine and prostaglandin E1. Pilatz A; Schultheiss D; Gabouev AI; Schlote N; Mertsching H; Jonas U; Stief CG BJU Int; 2005 Jun; 95(9):1351-7. PubMed ID: 15892829 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4). Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946 [TBL] [Abstract][Full Text] [Related]
6. Characterization of cyclic nucleotide and inositol 1,4,5-trisphosphate-sensitive calcium-exchange activity of smooth muscle cells cultured from the human corpora cavernosa. Krall JF; Fittingoff M; Rajfer J Biol Reprod; 1988 Nov; 39(4):913-22. PubMed ID: 2462920 [TBL] [Abstract][Full Text] [Related]
7. Rationale for the combination of PGE(1) and S-nitroso-glutathione to induce relaxation of human penile smooth muscle. Angulo J; Cuevas P; Moncada I; Martín-Morales A; Allona A; Fernández A; Gabancho S; Ney P; Sáenz de Tejada I J Pharmacol Exp Ther; 2000 Nov; 295(2):586-93. PubMed ID: 11046092 [TBL] [Abstract][Full Text] [Related]
8. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients. Fu Q; Yao DH; Jiang YQ Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421 [TBL] [Abstract][Full Text] [Related]
9. Erectile response to intracavernous injection of vasoactive drugs after penile prosthesis removal. Stief CG; Gall H; Scherb W; Bähren W Urology; 1990 Aug; 36(2):143-5. PubMed ID: 2385882 [TBL] [Abstract][Full Text] [Related]
10. Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. Shamloul R; Atteya A; Elnashaar A; Gadallah A; Zohdy W; Abdelsalam W J Sex Med; 2005 Jan; 2(1):117-20. PubMed ID: 16422914 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine. JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280 [No Abstract] [Full Text] [Related]
12. Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study. Shamloul R; El-Dakhly M; Ghanem H; Gadallah A; Mokhtar H J Sex Med; 2004 Nov; 1(3):310-3. PubMed ID: 16422961 [TBL] [Abstract][Full Text] [Related]
13. [Prostaglandin E1 in erectile dysfunction]. Porst H Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258 [TBL] [Abstract][Full Text] [Related]
14. Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan). Usta MF; Sanabria J; Bivalacqua TJ; Hellstrom WJ Int J Impot Res; 2004 Feb; 16(1):73-7. PubMed ID: 14963475 [TBL] [Abstract][Full Text] [Related]
15. Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. Mulhall JP; Daller M; Traish AM; Gupta S; Park K; Salimpour P; Payton TR; Krane RJ; Goldstein I J Urol; 1997 Nov; 158(5):1752-8; discussion 1758-9. PubMed ID: 9334594 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for an early increase in dose of vasoactive agents for intracavernous pharmacotherapy. Kim SC; Seo KK; Park BD; Lee SW Urol Int; 2000; 65(4):204-7. PubMed ID: 11112870 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine. Zentgraf M; Baccouche M; Jünemann KP Urol Int; 1988; 43(2):65-75. PubMed ID: 3291360 [TBL] [Abstract][Full Text] [Related]
18. Comparison of oral and intracavernosal vasoactive agents in penile erection. Lue T; Goldstein I; Traish A Int J Impot Res; 2000 Mar; 12 Suppl 1():S81-88. PubMed ID: 10845769 [TBL] [Abstract][Full Text] [Related]
19. Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study. Sahin M; Başar MM; Bozdoğan O; Atan A Urology; 2001 Sep; 58(3):487-92. PubMed ID: 11549511 [TBL] [Abstract][Full Text] [Related]
20. Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. Rajasekaran M; Mondal D; Agrawal K; Chen IL; Hellstrom W; Sikka S J Urol; 1998 Dec; 160(6 Pt 1):2210-5. PubMed ID: 9817372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]